Lumawan, Kerian Von A.
HRN: 21-34-16 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/27/2022
AMPICILLIN 1GM (VIAL)
11/27/2022
12/04/2022
IV
350mg
Q12
AGE With Mod. DHN
Waiting Final Action
Indication: Empiric Type of Infection: Intra-abdominal Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes